Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor

Increasing evidence showed that the substance P (SP)/neurokinin-1 receptor (NK1R) complex is involved in the development of several cancers. However, little is known about the mechanisms by which SP/NK1R complex plays a role in esophageal squamous cell carcinoma (ESCC) progression. RT-qPCR, CCK-8, T...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Yang, Sang, Meixiang, Liu, Fei, Gu, Lina, Li, Juan, Wu, Yunyan, Shan, Baoen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236268/
https://www.ncbi.nlm.nih.gov/pubmed/37203393
http://dx.doi.org/10.3892/or.2023.8568

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10236268/
https://www.ncbi.nlm.nih.gov/pubmed/37203393
http://dx.doi.org/10.3892/or.2023.8568

Ejemplares similares